Drawing for ZYBIO

USPTO serial 79240075

ZYBIO

Reviewed by CopyMark Law Group

Reg. 5876268Status 709
Filing date
Status date
Registration date
Oct 8, 2019
Examiner
FENNESSY, EDWARD JOHN
Law office
TMEG LAW OFFICE 101

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ZYBIO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Bacteriological preparations for medical and veterinary use; bacterial preparations for medical and veterinary use; chemical reagents for medical or veterinary purposes; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of infectious diseases; diagnostic preparations for medical purposes; chemical preparations for the diagnosis of pregnancy; antibiotics; vaccines; bacterial poisonsSECTION 71 - CANCELLED—
010Apparatus for use in medical analysis, namely, blood cell analyzer, blood flow analyzer, blood glucose meter, cell analysis system, electrolyte analysis system, electrolyte and biochemical analysis system, polymerase chain reaction machine for clinical, medical diagnostic, and therapeutic uses, nucleic acid extractor, enzyme label analyzer, enzyme immunoassay analyzer, glycated hemoglobin analyzer; diagnostic apparatus for medical purposes, namely, ultrasound detection system, electrocardiograph, chemiluminescence immunoanalyzer for analyzing blood serum, medical apparatus and instruments for diagnostic radiopharmaceutical use, blood coagulation detection system, diagnostic apparatus for detecting bladder infections, flow cytometers and flow-based analyzers providing cell and particle analysis, detection, or counting for medical, clinical, medical diagnostic, and therapeutic uses, diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing, arteriosclerosis monitor, medical diagnostic apparatus for testing and analyzing genital tract secretion, apparatus for blood analysis, sample preparation device for medical diagnostic uses, cell culture apparatus for medical use, namely, cell culture chambers; apparatus for use in medical analysis, namely, hematology analyzers for medical diagnostic uses, immunochemical testing apparatus for medical use, automatic biochemical analyzer for testing urine, blood, feces, saliva, cerebrospinal fluid in medical use, mass spectrometers for testing urine, blood, feces, saliva, cerebrospinal fluid for medical use; medical apparatus and instruments, namely, surgical apparatus and instruments, sample preparation instrument; POCT analyzer in the nature of nursing appliances, namely, medical diagnostic apparatus for testing blood sugar levels, Medical diagnostic apparatus for analyzing and measuring electrolytes in the body, medical diagnostic apparatus for analyzing and measuring blood coagulation, medical diagnostic apparatus for analyzing and measuring urine, blood, feces, saliva, cerebrospinal fluid; ophthalmometers; ophthalmoscopes; Uterine syringe for artificial insemination; blood transfusion apparatus; dialyzersSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 24, 2026C71TCANCELLED SECTION 71—
Jul 10, 2025ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Oct 8, 2024REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Feb 12, 2024ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Feb 12, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 21, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 3, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 3, 2020FIMPFINAL DISPOSITION PROCESSED—
Jan 8, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 8, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 30, 2019FIXDELECTRONIC RECORD REVIEW COMPLETE—
Aug 16, 2019ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Aug 11, 2019ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
May 1, 2019ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Apr 26, 2019CHLDCHANGE OF OWNER RECEIVED FROM IB—
Apr 19, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 2, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 2, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 13, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 22, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 22, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Feb 22, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 22, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 22, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 22, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Feb 22, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 22, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 22, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 6, 2019GNS1NOTIFICATION OF SUBSEQUENT FINAL EMAILED—
Feb 6, 2019GNCFCONTINUATION OF FINAL REFUSAL E-MAILED—
Feb 6, 2019CNCFACTION CONTINUING A FINAL - COMPLETED—
Jan 24, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 24, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 24, 2019ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jan 2, 2019GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jan 2, 2019GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 2, 2019CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 26, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 26, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 26, 2018ALIEASSIGNED TO LIE—
Nov 15, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 13, 2018RFNTREFUSAL PROCESSED BY IB—
Sep 21, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 21, 2018RFRRREFUSAL PROCESSED BY MPU—
Sep 18, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 18, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 17, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 12, 2018DOCKASSIGNED TO EXAMINER—
Sep 12, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 6, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance